Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzon Pharmaceuticals Inc (OTCQX US:ENZN)

0.242
Delayed Data
As of Jan 16
 0.00 / 0.00%
Today’s Change
0.03
Today|||52-Week Range
0.35
-10.37%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues853.0K1.4M6.8M151.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses146.0K349.0K337.0K335.0K
 
 
 
 
 
Total Operating Expenses146.0K349.0K337.0K335.0K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income707.0K1.1M6.4M-184.0K
 
 
 
 
 
Extraordinary Charge-54.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income653.0K1.1M6.4M-184.0K
 
 
 
 
 
Income Taxes-5.3M-446.0K-2.3M-337.0K
 
 
 
 
 
Net Income-4.6M645.0K4.2M153.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS44.2M44.2M44.2M44.2M
 
 
 
 
 
Shares To Calculate EPS Diluted44.2M44.2M44.2M44.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.11$0.01$0.09$0.00
 
 
 
 
EPS Diluted-$0.10$0.01$0.09$0.00